MGL and DC-SIGN recognize cancer-specific glycosylation changes of the mucin MUC1, in particular the carbohydrate sialyl LewisX and the sialyl TN epitope [60]; MUC1 and TAG-72 bind also the MR [27, 35, 36]. Here, CD209 is linked to cancer.